Kalvista Pharmaceuticals Inc banner

Kalvista Pharmaceuticals Inc
NASDAQ:KALV

Watchlist Manager
Kalvista Pharmaceuticals Inc Logo
Kalvista Pharmaceuticals Inc
NASDAQ:KALV
Watchlist
Price: 27 USD
Market Cap: $1.4B

Wall St Price Targets

KALV Price Targets Summary
Kalvista Pharmaceuticals Inc

There are no price targets for KALV.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Kalvista Pharmaceuticals Inc Competitors:
Price Targets
MRVL
Marvell Technology Group Ltd
29% Upside
PGEN
Precigen Inc
130% Upside
MTLS
Materialise NV
56% Upside
CFFN
Capitol Federal Financial Inc
-2% Downside

Revenue
Forecast

49% / Year
Past Growth
107% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
49% / Year
Past Growth
107% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 12 years, the compound annual growth rate for Revenue has been 49%. The projected CAGR for the next 3 years is 107%.

Gross Profit
Forecast

N/A
Past Growth
109% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
109% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 3 years is 109%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is KALV's stock price target?
Not Available

KALV does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
107%

Over the last 12 years, the compound annual growth rate for Revenue has been 49%. The projected CAGR for the next 3 years is 107%.

What is the Gross Profit forecast for Kalvista Pharmaceuticals Inc?
Projected CAGR
109%

The compound annual growth rate for Gross Profit over the next 3 years is 109%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett